









Markets
/
Stocks
/
nasdaq-neog
/

Neogen Corp

NEOG

8.700USD

-0.450-4.92%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

813.41MMarket Cap

LossP/E TTM



Neogen Corp

8.700

-0.450-4.92%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Neogen Corp

Currency: USD Updated: 2026-03-27

Key Insights

Neogen Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 43 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 11.00.In the medium term, the stock price is expected to trend up.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Neogen Corp's Score

Industry at a Glance

Industry Ranking

43 / 208

Overall Ranking

134 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Neogen Corp Highlights

StrengthsRisks

Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 894.66M.

Fairly Valued

The company’s latest PE is -3.13, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 243.60M shares, decreasing 27.81% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 202.39K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.77.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

11.000

Target Price

+20.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Neogen Corp is 6.86, ranking 108 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 224.69M, representing a year-over-year decrease of 2.84%, while its net profit experienced a year-over-year decrease of 96.51%.

Score

Industry at a Glance

Previous score

6.86

Change



Financials

4.98

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.40

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.64

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.93

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.35

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Neogen Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Neogen Corp is 8.77, ranking 8 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.13, which is -29519.00% below the recent high of 921.43 and -31155.82% above the recent low of -978.96.

Score

Industry at a Glance

Previous score

8.77

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 43/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Neogen Corp is 7.20, ranking 144 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 7.25, with a high of 10.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

7.20

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

11.000

Target Price

+20.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Neogen Corp

NEOG

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Neogen Corp is 6.78, ranking 63 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 10.56 and the support level at 7.54, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.06

Change

-0.28

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.102

Sell

RSI(14)

35.635

Neutral

STOCH(KDJ)(9,3,3)

50.529

Neutral

ATR(14)

0.482

Low Volatility

CCI(14)

-76.194

Neutral

Williams %R

73.021

Sell

TRIX(12,20)

-0.793

Sell

StochRSI(14)

2.137

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

8.992

Sell

MA10

8.926

Sell

MA20

9.508

Sell

MA50

10.114

Sell

MA100

8.465

Buy

MA200

6.964

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Neogen Corp is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 111.99%, representing a quarter-over-quarter decrease of 4.34%. The largest institutional shareholder is The Vanguard, holding a total of 23.76M shares, representing 10.92% of shares outstanding, with 0.84% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

29.26M

+6.18%

The Vanguard Group, Inc.

Star Investors

23.92M

+1.64%

Clarkston Capital Partners, LLC

11.69M

-16.51%

ING Bank N.V.

8.67M

-38.31%

State Street Investment Management (US)

8.75M

+1.84%

Gates Capital Management, Inc.

10.90M

-14.80%

Mackenzie Financial Corporation

7.82M

+0.08%

Dimensional Fund Advisors, L.P.

8.03M

-12.12%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Neogen Corp is 5.27, ranking 85 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.98. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.